MRI Screening of Second Primary Cancer Occurring Within Radiation Fields After Treatment by External Beam Radiation Therapy for Hereditary Retinoblastoma (DepiSCARRH)
NAActive, not recruitingINTERVENTIONAL
Enrollment
88
Participants
Timeline
Start Date
March 19, 2017
Primary Completion Date
March 31, 2034
Study Completion Date
March 31, 2034
Conditions
Hereditary Retinoblastoma
Interventions
PROCEDURE
MRI
MRI will be performed each year during 10 years.
Trial Locations (1)
75005
Institut Curie, Paris
All Listed Sponsors
lead
Institut Curie
OTHER
NCT03026998 - MRI Screening of Second Primary Cancer Occurring Within Radiation Fields After Treatment by External Beam Radiation Therapy for Hereditary Retinoblastoma (DepiSCARRH) | Biotech Hunter | Biotech Hunter